Six novel NPC1 mutations in Chinese patients with Niemann–Pick disease type C
- 1Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan
- 2Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan
- 3Department of Gynecology/Obstetrics, National Taiwan University Hospital, Taipei, Taiwan
- 4Department of Pediatrics, Kaoshiung Veteran General Hospital, Kaoshiung, Taiwan
- 5National Referral Laboratory, Department of Genetic Medicine, Women’s and Children’s Hospital, Adelaide, Australia
- 6Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
- Correspondence to: Dr Ming-Jen Lee Department of Medical Genetics, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei 100, Taiwan;
- Received 21 May 2004
- Accepted 24 June 2004
- Revised 3 June 2004
In patients with Niemann–Pick disease type C (NPC), an autosomal recessive lipid storage disorder, neurodegeneration can occur in early life. Vertical ophthalmoplegia and extrapyramidal signs may be seen. Cholestatic jaundice and hepatosplenomegaly occur frequently in patients with early onset disease, with bone marrow biopsies showing diffuse infiltration of foamy histiocytes. Cholesterol esterification in skin fibroblasts is reduced, resulting in intracellular accumulation of cholesterol. NPC1 mutations are responsible for the disease in ∼95% of patients. NPC1 encodes a 1278 amino acid protein which contains 13 transmembrane domains. Over 130 mutations have been identified in NPC1, with over a third present within an NPC1 specific cysteine-rich domain positioned in a large extracellular loop. It has been proposed that the defect in cholesterol homoeostasis is the cause of neuronal apoptosis, but the precise role of the NPC1 protein and the functional implications of its mutations remain unknown. Although NPC is routinely diagnosed by biochemical analysis, identification of molecular defects helps confirm the diagnosis and enables family studies, and rapid, accurate prenatal diagnosis. This report describe the analysis of the NPC1 gene in five Taiwanese/Chinese patients with NPC. Six novel NPC1 mutations (N968S, G1015V, G1034R, V1212L, S738Stop, and I635fs) were identified of which three are missense mutations located in the cysteine-rich domain. These are the first NPC1 mutations reported from Chinese patients with NPC.
This study was supported by a grant from National Taiwan University Hospital (NTUH 92A03-5).
Competing interests: none declared